Q3 2023 Vistin Pharma ASA Earnings Call Transcript
Good day, and thank you for standing by. Welcome to Vistin Pharma Quarterly Report for Q3 2023. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the call over to your first speaker today, Mr. Kjell-Erik Nordby, CEO of the company. Thank you. Please go ahead.
()
Thank you, and welcome to Vistin Pharma's third quarter reporting. We are happy to present another strong quarter for the company. We achieved all-time high revenue and also EBITDA and sales volume in the third quarter. The revenue and that NOK 120 million, which is a 30% increase compared to last year. The main driver for the increased revenue is that we had more volumes available for sale from second line that we installed in Q1 last year. Year-to-date, the revenue is NOK 328 million compared to NOK 194 million last year, and that is a total of 69% increase sales. EBITDA ended at NOK 27 million compared to negative NOK 3 million in the last -- in Q3
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
